Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donatella Marino

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Annali Dell'Istituto Superiore Di Sanita|April 2, 2016
Health facilities humanisation: design guidelines supported by statistical evidenceDaniela Bosia, Donatella Marino, Gabriella Peretti
Cancer Management and Research|June 18, 2020
Ramucirumab, A Second-Line Option For Patients With Hepatocellular Carcinoma: A Review Of The EvidenceEmmanuele De Luca, Donatella Marino, Massimo Di Maio
Hepatobiliary Surgery and Nutrition|February 27, 2014
Targeted agents: how can we improve the outcome in biliary tract cancer?Donatella Marino, Federica Colombi, Dario Ribero, et al.
Critical Reviews in Oncology/Hematology|July 20, 2012
Biliary tract carcinomas: from chemotherapy to targeted therapyDonatella Marino, Francesco Leone, Giuliana Cavalloni, et al.
Drugs in Context|April 27, 2019
Second-line treatment options in hepatocellular carcinomaDonatella Marino, Clizia Zichi, Marco Audisio, et al.
Critical Reviews in Oncology/Hematology|July 3, 2014
Potentially resectable metastatic colorectal cancer: an individualized approach to conversion therapyDonatella Marino, Francesco Leone, Francesca D'Avanzo, et al.
Expert Opinion on Emerging Drugs|February 23, 2018
Emerging molecular target antagonists for the treatment of biliary tract cancerPasquale Lombardi, Donatella Marino, Elisabetta Fenocchio, et al.
Critical Reviews in Oncology/Hematology|March 18, 2018
Fluoropyrimidine-induced cardiotoxicityIlaria Depetris, Donatella Marino, Alessandro Bonzano, et al.
Oncotargets and Therapy|June 6, 2015
Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncologyGiuseppe Aprile, Francesco Leone, Riccardo Giampieri, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?Giacomo Aimar, Chiara Paratore, Clizia Zichi, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Annali Dell'Istituto Superiore Di Sanita|April 2, 2016
Health facilities humanisation: design guidelines supported by statistical evidenceDaniela Bosia, Donatella Marino, Gabriella Peretti
Cancer Management and Research|June 18, 2020
Ramucirumab, A Second-Line Option For Patients With Hepatocellular Carcinoma: A Review Of The EvidenceEmmanuele De Luca, Donatella Marino, Massimo Di Maio
Hepatobiliary Surgery and Nutrition|February 27, 2014
Targeted agents: how can we improve the outcome in biliary tract cancer?Donatella Marino, Federica Colombi, Dario Ribero, et al.
Critical Reviews in Oncology/Hematology|July 20, 2012
Biliary tract carcinomas: from chemotherapy to targeted therapyDonatella Marino, Francesco Leone, Giuliana Cavalloni, et al.
Drugs in Context|April 27, 2019
Second-line treatment options in hepatocellular carcinomaDonatella Marino, Clizia Zichi, Marco Audisio, et al.
Critical Reviews in Oncology/Hematology|July 3, 2014
Potentially resectable metastatic colorectal cancer: an individualized approach to conversion therapyDonatella Marino, Francesco Leone, Francesca D'Avanzo, et al.
Expert Opinion on Emerging Drugs|February 23, 2018
Emerging molecular target antagonists for the treatment of biliary tract cancerPasquale Lombardi, Donatella Marino, Elisabetta Fenocchio, et al.
Critical Reviews in Oncology/Hematology|March 18, 2018
Fluoropyrimidine-induced cardiotoxicityIlaria Depetris, Donatella Marino, Alessandro Bonzano, et al.
Oncotargets and Therapy|June 6, 2015
Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncologyGiuseppe Aprile, Francesco Leone, Riccardo Giampieri, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?Giacomo Aimar, Chiara Paratore, Clizia Zichi, et al.
Pageof 3